0001638833-24-000071.txt : 20240313
0001638833-24-000071.hdr.sgml : 20240313
20240313164102
ACCESSION NUMBER: 0001638833-24-000071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Owens Bradley R.
CENTRAL INDEX KEY: 0001839389
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37576
FILM NUMBER: 24746548
MAIL ADDRESS:
STREET 1: 310 SEVEN SPRINGS WAY
STREET 2: SUITE 500
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surgery Partners, Inc.
CENTRAL INDEX KEY: 0001638833
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 473620923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 310 SEVEN SPRINGS WAY
STREET 2: SUITE 500
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
BUSINESS PHONE: 615-234-5900
MAIL ADDRESS:
STREET 1: 310 SEVEN SPRINGS WAY
STREET 2: SUITE 500
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
4
1
wk-form4_1710362450.xml
FORM 4
X0508
4
2024-03-11
0
0001638833
Surgery Partners, Inc.
SGRY
0001839389
Owens Bradley R.
C/O SURGERY PARTNERS, INC.
340 SEVEN SPRINGS WAY, SUITE 600
BRENTWOOD
TN
37027
0
1
0
0
National Group President
0
Common Stock
2024-03-11
4
S
0
632
29.49
D
81121
D
Common Stock
2024-03-12
4
S
0
968
29.82
D
80153
D
Common Stock
2024-03-12
4
S
0
1815
29.82
D
78338
D
Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 10, 2024.
The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 11, 2024.
/s/ Jennifer Baldock, Attorney-in-Fact
2024-03-13